2828
C.-C. Hsu et al. / Tetrahedron 65 (2009) 2824–2829
4. Experimental
(860 mg, 8.8 mmol) were added to a degassed solution of the
dibromide 8 (1.0 g, 2.2 mmol) in triethylamine (15 mL) and then the
mixture was heated at 40 ꢁC for 12 h. After cooling to room tem-
perature, the solution was partitioned between CH2Cl2 (10 mL) and
H2O (10 mL), the aqueous phase was extracted with CH2Cl2
(2ꢂ10 mL), and the combined organic phases were dried (MgSO4),
concentrated, and purified chromatographically (SiO2: CH2Cl2/hex-
ane, 1:3) to afford the carbamate 9 as a yellow liquid (893 mg, 83%).
4.1. General
All glassware, stirrer bars, syringes, and needles were either
oven- or flame-dried prior to use. All reagents, unless otherwise
indicated, were obtained from commercial sources. Anhydrous
CH2Cl2 and MeCN were obtained through distillation from CaH2
under N2. Anhydrous THF was obtained through distillation from
Na/Ph2CO under N2. Reactions were conducted under N2 or Ar at-
mospheres. Thin layer chromatography (TLC) was performed on
Merck 0.25-mm silica gel (Merck Art. 5715). Column chromatog-
raphy was undertaken over Kieselgel 60 (Merck, 70–230 mesh).
Melting points are uncorrected. Ball-milling was performed using
a Retsch MM 200 swing-mill, containing two 5-mL stainless-steel
cells and two stainless-steel balls (diameter: 7 mm); the mill was
operated at a frequency of 22.5 Hz at room temperature. In NMR
spectra, the deuterated solvent was used as the lock; the role of the
internal standard was played by either TMS or the solvent’s residual
protons. Chemical shifts are reported in parts per million (ppm).
Multiplicities are given as s (singlet), d (doublet), t (triplet), q
(quartet), m (mutiplet), and br (broad).
1H NMR (400 MHz, CDCl3):
d
¼0.24 (s,18H),1.44 (s, 9H), 4.24 (br, 2H),
4.36 (br, 2H), 7.00–7.18 (br, 4H), 7.39 (d, J¼8 Hz, 4H); 13C NMR
(100 MHz, CDCl3):
d
¼0.4, 28.6, 49.4, 80.1, 93.9, 104.6, 121.7, 126.6,
127.3, 131.6, 137.7, 155.0; HRMS (ESI): m/z calcd for (C29H39NO2Si2)
[MþNa]: 512.2417; found: 512.2417.
4.5. Ammonium salt 10-H$PF6
K2CO3 (1 g, 7.2 mmol) was added to a solution of the carbamate
9 (890 mg, 1.8 mmol) in MeOH (20 mL). The mixture was stirred at
room temperature for 30 min and partitioned between CH2Cl2
(20 mL) and H2O (20 mL). The aqueous phase was washed with
CH2Cl2 (2ꢂ20 mL) and then the combined organic phases were
concentrated to give a yellow liquid, which was dissolved in
a mixture of MeOH (15 mL) and trifluoroacetic acid (5 mL) and
stirred at room temperature for 12 h. Saturated aqueous NH4PF6
solution (30 mL) was added to the mixture and then the organic
solvent was evaporated. The precipitate was filtered off and washed
with H2O to afford the ammonium salt 10-H$PF6 as a white solid
(610 mg, 85%). Mp¼210–211 ꢁC; 1H NMR (400 MHz, CD3CN):
4.2. [2]Rotaxane 6-H$PF6
The organic solvent was evaporated under reduced pressure
from a mixture of macrocycle 1 (100 mg, 0.24 mmol), the alkyne 2-
H$PF6 (100 mg, 0.24 mmol), and silica gel (200 mg) in CH3NO2
(10 mL) to afford a solid mixture, which was then mixed with 3,6-
diphenyl-1,2,4,5-tetrazine (61 mg, 0.26 mmol) and ball-milled at
room temperature for 1 h. The solid mixture was transferred to
a 5 mL flask, heated to 100 ꢁC for 3 days, and then purified chro-
matographically (SiO2: MeOH/CH2Cl2, 2:98) to afford the [2]rotax-
ane 6-H$PF6 as a white solid (153 mg, 61%). Mp¼173–174 ꢁC; 1H
d
¼3.50 (s, 2H), 4.23 (s, 4H), 7.44 (dd, J¼8 Hz, 4H), 7.56 (d, J¼8 Hz,
4H); 13C NMR (100 MHz, CD3CN):
d
¼51.9, 80.3, 83.1, 124.2, 131.2,
131.7, 133.2; HRMS (ESI): m/z calcd for [10-H]þ (C18H16N): 246.1277;
found: 246.1283.
4.6. [2]Rotaxane 11-H$PF6
NMR (400 MHz, CD3CN):
d
¼1.05 (t, J¼7 Hz, 2H), 1.41 (s, 9H), 2.99 (t,
J¼6 Hz, 2H), 3.02–3.09 (m, 2H), 3.26–3.31 (m, 2H), 3.55–3.60 (m,
4H), 3.80 (d, J¼9 Hz, 2H), 4.28 (d, J¼9 Hz, 2H), 5.27 (dd, J¼25, 15 Hz,
4H), 5.97–6.02 (m, 4H), 6.35 (dd, J¼8, 2 Hz, 2H), 6.95 (dd, J¼9, 3 Hz,
2H), 7.10–7.21 (m, 6H), 7.37 (s, 4H), 7.39–7.54 (m, 7H), 7.55–7.63 (m,
5H), 8.10 (s, 1H), 8.27 (dd, J¼7, 2 Hz, 2H); 13C NMR (100 MHz,
After evaporating (under reduced pressure) the solvent from
a mixture of the macrocycle 1 (108 mg, 0.25 mmol), the dialkyne
10-H$PF6 (100 mg, 0.25 mmol), and silica gel (208 mg) in CH3NO2
(10 mL), the solid obtained was mixed with 3,6-diphenyl-1,2,4,5-
tetrazine (132 mg, 0.56 mmol) and ball-milled at room tempera-
ture for 1 h. The solid mixture was transferred to a 5 mL flask,
heated at 100 ꢁC for 3 days, and then purified chromatographically
(SiO2: MeOH/CH2Cl2, 2:98) to afford the [2]rotaxane 11-H$PF6 as
a yellow solid (210 mg, 72%). Mp¼195–196 ꢁC; 1H NMR (400 MHz,
CD3CN):
d
¼31.5, 35.5, 49.1, 52.5, 68.2, 69.8, 71.3, 74.4, 115.0, 125.6,
126.6, 126.8, 127.2, 127.9, 128.0, 129.0, 129.2, 129.4, 129.9, 129.9,
130.7, 131.0, 131.3, 131.7, 132.2, 132.9, 137.0, 137.0, 138.2, 138.3, 139.8,
154.1, 158.0, 158.7; HRMS (ESI): m/z calcd for [6-H]þ (C60H62N3O5):
904.4684; found: 904.4689.
CD3CN):
d
¼2.01 (t, J¼7 Hz, 4H), 3.06–3.12 (m, 4H), 3.50–3.56 (m,
4H), 4.05 (s, 4H), 5.29 (s, 4H), 6.60–6.73 (m, 12H), 7.37–7.47 (m,
4.3. tert-Butyl bis(4-bromobenzyl)carbamate (8)
16H), 7.49–7.64 (m, 10H), 8.10 (s, 2H), 8.28 (dd, J¼7, 2 Hz, 4H); 13C
NMR (100 MHz, CD3CN):
d
¼51.1, 68.2, 69.9, 71.2, 74.4, 116.7, 125.8,
Di-tert-butyl dicarbonate (570 mg, 2.6 mmol) and triethylamine
(390 mg, 3.9 mmol) were added to a solution of the dibromide 7
(920 mg, 2.59 mmol) in MeOH (15 mL) and then the mixture was
stirred at room temperature for 24 h. The organic solvent was
evaporated under reduced pressure and the crude product purified
chromatographically (SiO2: CH2Cl2/hexane, 1:1) to yield the Boc-
protected dibromide 8 as a yellow liquid (0.84 g, 72%). 1H NMR
127.9, 128.0, 129.1, 129.1, 129.2, 129.5, 129.9, 130.4,130.7, 131.0, 131.6,
132.0, 136.9, 138.1, 138.2, 138.4, 139.5, 158.1, 158.6, 159.3; HRMS
(ESI): m/z calcd for [11-H]þ (C72H64N5O5): 1078.4902; found:
1078.4907.
4.7. [2]Rotaxane 12-H$PF6
(400 MHz, CDCl3):
d
¼1.47 (s, 9H), 4.24 (br, 2H), 4.33 (br, 2H), 6.98–
After evaporating (under reduced pressure) the solvent from
a mixture of DB24C8 (390 mg, 0.3 mmol), the alkyne 2-H$PF6
(300 mg, 0.24 mmol), and silica gel (690 mg) in CH3NO2 (10 mL),
the solid mixture obtained was mixed with 3,6-diphenyl-1,2,4,5-
tetrazine (180 mg, 0.78 mmol), ball-milled at room temperature for
1 h, transferred to a 5 mL flask, and heated at 100 ꢁC for 3 days.
After cooling to room temperature, the resulting solid mixture was
purified chromatographically (SiO2: MeOH/CH2Cl2, 2:98) to afford
the [2]rotaxane 12-H$PF6 as a white solid (560 mg, 73%). Mp¼124–
7.10 (br, 4H), 7.43 (d, J¼8 Hz, 4H); 13C NMR (100 MHz, CDCl3):
d
¼28.4, 48.7, 49.0, 80.4,121.0,128.8,129.4,131.5,136.6,155.5; HRMS
(ESI): m/z calcd for (C19H21Br2NO2) [MþNa]: 475.98367; found:
475.98367.
4.4. tert-Butyl bis{4-[(trimethylsilyl)ethynyl]-
benzyl}carbamate (9)
Tetrakis(triphenylphosphine)palladium(0) (101 mg, 0.09 mmol),
copper iodide (16.7 mg, 0.09 mmol), and trimethylsilylacetylene
125 ꢁC; 1H NMR (400 MHz, CD3CN):
d
¼1.23 (s, 9H), 3.42–3.57 (m,
8H), 3.63–3.80 (m, 8H), 3.98–4.06 (m, 8H), 4.54 (t, J¼6 Hz, 2H), 4.74